Apexigen Inc (APGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -12,100 | -6,053 | -32,069 | -25,638 | -17,146 |
| Depreciation Amortization | 902 | 458 | 819 | 376 | 62 |
| Accounts payable and accrued liabilities | -2,005 | -2,798 | 317 | -1,955 | 2,058 |
| Other Working Capital | 98 | -1,906 | -1,770 | -3,822 | 1,953 |
| Other Operating Activity | 3,342 | 3,537 | 2,010 | 3,399 | -1,069 |
| Operating Cash Flow | $-9,763 | $-6,762 | $-30,693 | $-27,640 | $-14,142 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 150 | 150 | -57 | -57 | -43 |
| Purchase Of Investment | N/A | N/A | -18,945 | -18,945 | -14,985 |
| Sale Of Investment | 2,000 | 2,000 | 29,957 | 23,932 | 17,947 |
| Investing Cash Flow | $2,150 | $2,150 | $10,955 | $4,930 | $2,919 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 2,791 | 2,791 | N/A | 18,094 | N/A |
| Common Stock Issued | 5 | N/A | 20,704 | 2,610 | 73 |
| Other Financing Activity | -616 | -251 | -9,607 | -8,729 | -649 |
| Financing Cash Flow | $2,180 | $2,540 | $11,097 | $11,975 | $-576 |
| Beginning Cash Position | 14,802 | 14,802 | 23,443 | 23,443 | 23,443 |
| End Cash Position | 9,369 | 12,730 | 14,802 | 12,708 | 11,644 |
| Net Cash Flow | $-5,433 | $-2,072 | $-8,641 | $-10,735 | $-11,799 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,763 | -6,762 | -30,693 | -27,640 | -14,142 |
| Capital Expenditure | N/A | N/A | -57 | -57 | -43 |
| Free Cash Flow | -9,763 | -6,762 | -30,750 | -27,697 | -14,185 |